Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 20, 2024Journal of Cancer Research and Clinical OncologyOpen Access

Does autoimmune disease impair the survival of hepatocellular carcinoma patients undergoing liver resection? A multi-institutional observational study

View Full Paper
Ask AI
Bookmark
Share

Authors

CLChao‐Wei LeeHCHsing‐Yu ChenPTPing‐Han Tsai

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lee et al. (2024) studied this question.

synapsesocial.com/papers/68e5fa66b6db64358758ea04https://doi.org/10.1007/s00432-024-05885-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study2022 · 86 citations
  2. 2Association Between Systemic Lupus Erythematosus and Cancer Morbidity and Mortality: Findings From Cohort Studies2022 · 62 citations
  3. 3Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases2021 · 31 citations